BioCentury | Aug 1, 2020
Tools & Techniques

Lurie winner and incoming Genentech R&D chief Aviv Regev looks to gene programs to untangle complex diseases

...us to find these programs. And the ability to couple different types of data -- epigenomics...
BioCentury | Jan 2, 2020
Clinical News

Durect looks ahead to liver indications after Phase IIa miss in psoriasis

Although the failure of topical DUR-928 in a Phase IIa psoriasis trial vaporized more than a quarter of Durect’s market cap on Thursday, the company is pressing on with clinical studies of injectable and oral...
BioCentury | Nov 14, 2019
Tools & Techniques

Weizmann 10K Project aims for -omics sweet spot

...each person’s genetics, oral microbiome and gut microbiome, and capture molecular signatures such as transcriptomics, epigenomics...
BioCentury | Oct 17, 2019
Emerging Company Profile

Parker Institute’s ArsenalBio launches with $85M to build cell engineering war chest

...of discovery oncology in January. Co-founders Bradley Bernstein and Kole Roybal bring expertise in cancer epigenomics...
BioCentury | Oct 3, 2019
Targets & Mechanisms

Stimulating heart regeneration following injury

A multi-omic study of regenerating neonatal hearts has uncovered novel therapeutic targets for cardiac injury post myocardial infarction. Study leader Eric Olson said the findings serve as a resource for understanding the DNA sequences and...
BioCentury | Sep 12, 2019
Preclinical News

Sept. 12 Preclinical Quick Takes: Stephen Quake newco reveals epigenomic platform; plus Personal Genome, Summit and Biolife4D

Bluestar’s epigenomic platform IDs breast, pancreatic cancer Bluestar Genomics Inc. (San Francisco, Calif.) showed it correctly identified breast and pancreatic cancers with areas under the curve of 0.89 and 0.95, respectively, with its machine learning...
BioCentury | Mar 29, 2019
Company News

Guardant Health to acquire fellow cancer diagnostic company Bellwether Bio

...an undisclosed sum. Bellwether Bio Inc. (Seattle, Wash.) is developing cancer diagnostics based on the epigenomics...
BioCentury | Mar 2, 2019
Politics, Policy & Law

Sharpless focus on pediatric cancer

National Cancer Institute Director Norman “Ned” Sharpless hopes to parlay a State of the Union pediatric cancer funding commitment into a big data initiative that could serve as a model for advancing the search for...
BioCentury | Jan 30, 2019
Translation in Brief

Epigenetic links in endometriosis

An HDAC3-mediated epigenetic pathway could lead to new therapies and markers for endometriosis and associated infertility. Researchers from Michigan State University and Yonsei University College of Medicine have linked an epigenetic pathway involving HDAC3 to...
BioCentury | Jan 18, 2019
Targets & Mechanisms

Exploring 3-D genomic white space

...is assistant professor of pediatric oncology at Dana-Farber Cancer Institute, and an institute member and Epigenomics...
Items per page:
1 - 10 of 300
BioCentury | Aug 1, 2020
Tools & Techniques

Lurie winner and incoming Genentech R&D chief Aviv Regev looks to gene programs to untangle complex diseases

...us to find these programs. And the ability to couple different types of data -- epigenomics...
BioCentury | Jan 2, 2020
Clinical News

Durect looks ahead to liver indications after Phase IIa miss in psoriasis

Although the failure of topical DUR-928 in a Phase IIa psoriasis trial vaporized more than a quarter of Durect’s market cap on Thursday, the company is pressing on with clinical studies of injectable and oral...
BioCentury | Nov 14, 2019
Tools & Techniques

Weizmann 10K Project aims for -omics sweet spot

...each person’s genetics, oral microbiome and gut microbiome, and capture molecular signatures such as transcriptomics, epigenomics...
BioCentury | Oct 17, 2019
Emerging Company Profile

Parker Institute’s ArsenalBio launches with $85M to build cell engineering war chest

...of discovery oncology in January. Co-founders Bradley Bernstein and Kole Roybal bring expertise in cancer epigenomics...
BioCentury | Oct 3, 2019
Targets & Mechanisms

Stimulating heart regeneration following injury

A multi-omic study of regenerating neonatal hearts has uncovered novel therapeutic targets for cardiac injury post myocardial infarction. Study leader Eric Olson said the findings serve as a resource for understanding the DNA sequences and...
BioCentury | Sep 12, 2019
Preclinical News

Sept. 12 Preclinical Quick Takes: Stephen Quake newco reveals epigenomic platform; plus Personal Genome, Summit and Biolife4D

Bluestar’s epigenomic platform IDs breast, pancreatic cancer Bluestar Genomics Inc. (San Francisco, Calif.) showed it correctly identified breast and pancreatic cancers with areas under the curve of 0.89 and 0.95, respectively, with its machine learning...
BioCentury | Mar 29, 2019
Company News

Guardant Health to acquire fellow cancer diagnostic company Bellwether Bio

...an undisclosed sum. Bellwether Bio Inc. (Seattle, Wash.) is developing cancer diagnostics based on the epigenomics...
BioCentury | Mar 2, 2019
Politics, Policy & Law

Sharpless focus on pediatric cancer

National Cancer Institute Director Norman “Ned” Sharpless hopes to parlay a State of the Union pediatric cancer funding commitment into a big data initiative that could serve as a model for advancing the search for...
BioCentury | Jan 30, 2019
Translation in Brief

Epigenetic links in endometriosis

An HDAC3-mediated epigenetic pathway could lead to new therapies and markers for endometriosis and associated infertility. Researchers from Michigan State University and Yonsei University College of Medicine have linked an epigenetic pathway involving HDAC3 to...
BioCentury | Jan 18, 2019
Targets & Mechanisms

Exploring 3-D genomic white space

...is assistant professor of pediatric oncology at Dana-Farber Cancer Institute, and an institute member and Epigenomics...
Items per page:
1 - 10 of 300